The heart in sepsis and MODS;Das Herz bei Sepsis und MODS

Wiener Klinische Wochenschrift, Supplement

Volumn , Issue 1, 1997, Pages 3-24

  Muller Werdan U ^a   Prondzinsky, R ^a   Witthaut, R ^a   Stache, N ^a   Heinroth, K ^a   Kuhn, C ^a   Schmidt, H ^a   Busch, I ^a   Werdan, K ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiomyopathy; Multiple organ dysfunction syndrome (MODS); Sepsis; Septic cardiomyopathy; SIRS

Indexed keywords

EID: 0030639377     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (200)

1. Schuster H-P (1996) Intensivtherapie bei Sepsis und Multiorganversagen, 2. Aufl. Springer. Berlin Heidelberg New York Tokyo
2. Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137-1143
3. Werdan K, Boekstegers P, Müller U, Pfeifer A, Pilz G, Reithmann C, et al (1991) Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med Klin 86:526-534
4. Romberg E (1921) Die septische akute Myokarditis. In: Romberg E (Hrsg) Lehrbuch der Krankheiten des Herzens und der Blutgefäße, 3. Aufl. Ferdinand Enke, Stuttgart, S 494
5. Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart: molecular mechanisms of septic cardiomyopathy. R.G. Landes Company. Georgetown USA/Chapman & Hall, New York USA, Springer. Berlin Heidelberg New York Tokyo
6. Vincent J-L, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C, Kahn RJ (1992) Myocardial depression characterizes the fatal course of septic shock. Surgery 111:660-667
7. Parrillo JE (1989) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40:469-485
8. Werdan K (1996) Prophylaxe und Therapie der akuten septischen Kardiomyopathie. In: Schuster H-P (Hrsg) Intensiv-therapie bei Sepsis und Multiorganversagen. Springer, Berlin Heidelberg New York Tokyo, S 200-248
9. Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdarias JP (1990) Sepsis-related cardiogenic shock. Crit Care Med 18:1055-1060
10. Pilz G, McGinn P, Boekstegers P, Käab S, Weidenhöfer S, Werdan K (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circ Shock 42:174-182
11. Silverman HJ, Penaranda R, Orens JB, Lee NH (1993) Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21:31-39
12. Raper R, Sibbald WJ, Driedger AA, Gerow K (1989) Relative myocardial depression in normotensive sepsis J Crit Care 4:9-18
13. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, Levy H (1996) Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 24:252-258
14. Parrillo JE (1989) Septic shock in humans: clinical evaluation, pathogenesis, and therapeutic approach. In: Shoe-maker WC, Ayres S, Grenvik A, Holbrook PR, Thompson WL (eds) Textbook of critical care, 2nd edn. Saunders. Philadelphia, pp 1006-1024
15. Niemer M, Nemes C, Lundsgaard-Hansen P, Blauhut B (1992) Datenbuch Intensivmedizin (Datenbuch Anästhesiologie und Intensivmedizin, Bd 2). Fischer, Stuttgart Jena New York
16. Supinski G, Nethery D, Stofan D, DiMarco A (1996) Comparison of the effects of endotoxin on limb, respiratory and cardiac muscles. J Appl Physiol 81:1370-1378
17. Hopkins PM (1996) Human recombinant TNFα affects rat diaphragm muscle in vitro. Intensive Care Med 22:359-362
18. Gutierrez G, Hurtado FJ, Fernandez E (1995) Inhibitory effect of Escherichia coli endotoxin on skeletal muscle contractility. Crit Care Med 23:308-315
19. Parker MM, McCarthy KE, Ognibene RP, Parrillo JE (1988) Septic shock in humans produces similar patterns of left and right ventricular dysfunction and dilatation. Clin Res 36:373A
20. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, et al (1996) The acute respiratory distress syndrome: definitions, severity and clinical outcome - An analysis of 101 clinical investigations. Intensive Care Med 22:519-529
21. Knaus WA (1996) The ongoing mystery of ARDS. Intensive Care Med 22:517-518
22. Garber BG, Hebert PC, Yelle J-D, Hodder RV, McGowan J (1996) Adult respiratory distress syndrome: A systematic overview of incidence and risk factors. Crit Care Med 24:687-695
23. Prondzinsky R, Stache N, Witthaut R, Winkler M, Fraunberger P, Walli AK, et al (1997) Multi-organ-failure (MOF) with and without sepsis: differences in incidence and pattern of detected arrhythmias. Crit Care 1 [suppl] 1:S42
24. Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU. J Surg Res 63:11-16
25. Garrard CS, Kontoyannis DA, Piepoli M (1993) Spectral analysis of heart rate variability in sepsis syndrome. Clin Auton Res 3:5-13
26. Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107-1116
27. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, et al (1996) Experimental human endotoxemia increases cardiac regularity: Results from a prospective, randomized, crossover trial. Crit Care Med 24:1117-1124
28. Krafft P, Fridrich P, Steltzer H, Hammerle AF (1994) Continuous cardiopulmonary monitoring and its impact on survival. In: Hammerle AF (ed) MODS - Multiple-organ dysfunction syndrome (Intensive Care Medicine in Dialogue). Wilhelm Maudrich, Wien München Bern, pp 40-44
29. Jacquet L, Hanique G, Glorieux D, Matte P, Goenen M (1996) Analysis of the accuracy of continuous thermodilution cardiac output measurement - Comparison with intermittent thermodilution and Pick cardiac output measurement. Intensive Care Med 22:1125-1129
30. Prien Th, Wuchkow J (1996) Schwankungsbreite des Herzzeitvolumens bei hyperdynamer Sepsis. Vergleich von Bolus- und kontinuierlicher Thermodilutionsmethode. Intensivmed 33:178-182
31. Wippermann C-F, Huth RG, Schmidt FX, Thul J, Betancor M, Schranz D (1996) Continuous measurement of cardiac output by the Fick principle in infants and children: comparison with the thermodilution method. Intensive Care Med 22:467-171
32. Haller M, Zöllner C, Briegel J, Forst H (1995) Evaluation of a new continuous thermodilution cardiac output monitor in citically ill patients: A prospective criterion standard study. Crit Care Med 23:860-866 (Letters to the Editor: 1996;24:716-717)
33. Mihaljevic T, von Segesser LK, Tönz M, Leskosek B, Seifert B, Jenni R et al (1995) Continuous versus bolus thermodilution cardiac output measurements - A comparative study. Crit Care Med 23:944-949
34. Jardin F, Valtier B, Beauchet, Dubourg O, Boudarias JP (1994) Invasive monitoring combined with two-dimensional echocardiosraphic study in septic shock. Intensive Care Med 20:550-554
35. Daniel WG, Mügge A (1995) Transesophageal echocardiography. N Engl J Med 332:1268-1279
36. Gorscan J (1995) Quantification of left ventricular function using transesophageal echocardiography. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine 1995. Springer, Berlin Heidelberg New York Tokyo, pp 575-592
37. Smail N, Descorps Declere A, Duranteau J, Vigue B, Samii K (1996) Left ventricular function after severe trauma. Intensive Care Med 22:439-442
38. McLean AS (1996) Echocardiography in the intensive care unit. Intensive Care World 13:12-16
39. Natanson C, Hoffman WD, Parrillo JE (1995) Septic shock and multiple organ failure. In: Parrillo JE, Bone RC (eds) Critical care medicine - principles of diagnosis and management. Mosby, St. Louis, pp 355-374
40. McLuckie A (1996) The COLD system of haemodynamic monitoring. Intensive Care World 13:24-28
41. Van der Meer BJM, de Vries PMJ (1995) Impedance cardiography: non-invasive monitoring of hemodynamics in the ICU. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine 1995. Springer. Berlin Heidelberg New York Tokyo, pp 615-628
42. Van der Meer BJM, Woltjer HH, Sousman AM, Schreuder WO, Bulder ER, Huybregts. et al (1996) Impedance cardiography - Importance of the equation and the electrode configuration. Intensive Care Med 22:1120-1124
43. Van der Meer NJM, de Vries PMJM (1996) The reliability and applicability of impedance cardiography in the ICU. Intensivmed 33:495-500
44. Werdan K (1996) Phonokardiographie und sphygmographische Methoden. In: Erdmann E, Riecker G (Hrsg) Klinische Kardiologie. Springer, Berlin Heidelberg New York Tokyo, S 24-39
45. Sasse SA, Chen PA, Mahutte CK (1996) Relationship of changes in cardiac output to changes in heart rate in medical ICU patients. Intensive Care Med 22:409-414
46. Vincent J-L, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al (1996) The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/ failure. Intensive Care Med 22:707-710
47. Raper RF, Sibbald WJ (1988) The effects of coronary artery disease on cardiac function in nonhypotensive sepsis. Chest 94:507
48. Pilz G, Stäblein A, Reuschel-Janetschek E, Autenrieth G, Werdan K (1989) The use of scoring systems in patients with cardiogenic and septic shock. In: Schlag G. Redl H (eds) Second Vienna shock forum (Progress in clinical and biological research, vol 308), Liss, New York, pp 625-631
49. Conrad SA, Finkelstein JL, Madden MR, Burk J, Goodwin CW (1990) Cardiovascular dysfunction in multiple organ failure. In: Deitch EA (ed) Multiple organ failure - pathophysiology and basic concepts of therapy. Thieme, New York, pp 172-191
50. Law WR (1992) Myocardial depression. In: Gamelli RL, Dries DJ (eds) Trauma 2000 - Strategies for the new millenium. Landes, Austin USA, pp 30-35
51. Traber DL, Meyer J, Traber LD (1993) Cardiac function during hypovolemia. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin, Heidelberg New York Tokyo, pp 194-199
52. Hoffmann JN, Hartl W, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367
53. Prondzinsky R, Müller-Werdan U, Pilz G, Witthaut R, Stabenow I, Werdan K (1997) Systemische Entzündungsreaktion extrakorporaler Therapieverfahren (II): Der kardiopulmonale Bypass. Wien Klin Wochenschr 109 (in Druck)
54. Müller-Höcker J, Haerty W (1993) Pathomorphological aspects of the heart in septic patients. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer. Berlin Heidelberg New York Tokyo, pp 853-858
55. Goddard CM, Allard MF, Hogg JC, Walley KR (1996) Myocardial morphometric changes related to decreased contractility after endotoxin. Am J Physiol 270:H1446-H1452
56. Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ (1990) Histologic and ultrastructural changes in non pulmonary organs during early hyperdynamic sepsis. Surgery 107:397-410
57. Ince C, Ashruf JF, Avontuur JAM Wieringa PA, Spaan JAE, Bruining HA (1993) Heterogeneity of the hypoxic state in rat heart is determined at capillary level. Am Physiol 264:H294-H301
58. Gotloib L, Shostak A, Galdi P, Jaichenko J, Fudin R (1992) Loss of microvascular negative charges accompanied by interstitial edema in septic rats heart. Circulatory Shock 36:45-56
59. Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K, Satodate R (1996) Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 427:503-509
60. Sibbald WJ (1992) Circulatory dysfunction in sepsis. In: Peter K, Lawin P, Bein T, Pollwein B, Schelling G (Hrsg) Intensivmedizin 1992 (Intensivmedizin Notfallmedizin Anaesthesiologie Band 81, Reihen-Hrsg:. Lawin P, v Loewenich V, Schuster H-P, Stoeckel H, Zumtobel V). G Thieme, Stuttgart New York, S 81-88
61. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE (1986) The coronary circulation in human septic shock. Circulation 1986 73:637-644
62. Dhainaut JF, Huyghebaert M-F, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunei F et al (1987) Coronary hemodynamics and myocardial metabolism of lactate. free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75:533-541
63. Dhainaut J-F, Dall'Ava J, Mira JP (1993) Coronary hemodynamics and myocardial metabolism in sepsis and septic shock. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York Tokyo, pp 882-892
64. Elkins RC, McCurdy JR, Brown PP, Greenfield LJ (1973) Effects of coronary perfusion on myocardial performance during endotoxin shock. Surg Gynecol Obstet 137:991-996
65. Hinshaw LB, Archer LT, Spitzer JJ, Black MR, Peyton MD, Greenfield LJ (1974) Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 227:1051-1057
66. Fish RE, Lang CH, Spitzer JA (1986) Regional blood flow during continuous low-dose endotoxin infusion. Circulatory Shock 18:267-275
67. 2 availability depresssed in normotensive hyperdynamic sepsis? Crit Care Med 20:S55
68. Bloos F, Sibbald WJ (1994) Cardiocirculation in sepsis. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis - Current perspectives in pathophysiology and therapy (Update in intensive care and emergency medicine 18). Springer, Berlin Heidelberg New York Tokyo, pp 139-149
69. Snow TR, Dickey DT, Hinshaw LB, et al (1990) Early myocardial dysfunction induced with endotoxin in rhesus monkeys. Can J Cardiol 6:130-136
70. Bloos, FM, Morisaki HM, Neal AM, Martin CM, Ellis CG, Sibbald WJ, Pitt ML (1996) Sepsis depresses the metabolic oxygen reserve of the coronary circulation in mature sheep. Am J Respir Crit Care Med 153:1577-1584
71. Ulatowski JA, Nishikawa T, Matheson-Urbaitis B, Bucci E, Traystman RJ, Koehler RC (1996) Regional blood flow alterations after bovine fumaryl ββ-crosslinked hemoglobin transfusion and nitric oxide synthase inibition. Crit Care Med 24:558-565
72. Menger MD, Vollmar B, Messmer K (1994) Sepsis and nutritional blood flow. In: Reinhart K, Eyrich K, Sprung K (eds) Sepsis - Current perspectives in pathophysiology and therapy (Update in intensive care and emergency medicine 18, Vincent J-L, series editor). Springer. Berlin Heidelberg New York Tokyo, pp 163-173
73. Boekstegers P, Weidenhöfer S, Pilz G, Werdan K (1991) Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 19:317-323
74. 2 after administration of anti-TNF-α-antibody in patients with severe sepsis: comparison of interleukin-6 serum levels, APACHE II, and Elebute scores. Shock 1:246-253
75. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K (1994) Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 22:640-650
76. 2 transport and tissue oxygenation in septic shock. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis - current perspectives in pathophysiology and therapy (Update in intensive care and emergency medicine 18). Springer, Berlin Heidelberg New York Tokyo, pp 193-213
77. Trumbeckaite S, Hertel K,Durrieu G, Gellerich FN, Muller-Werdan U, Zierz S, et al (1997) Disturbance of energy metabolism in acute septic cardiomyopathy: decreased activities of the complexes I and II of the mitochondrial respiratory chain and phosphofructokinase. Crit Care 1 [Suppl] 1:S105
78. Crouser ED, Dorinsky PM (1996) Metabolic consequences of sepsis correlation with altered intracellular calcium homeostasis. Clinics Chest Med 17:249-261
79. Gamrin L, Essen P, Forsberg AM, Hultman E, Wemerman J (1996) A descriptive study of skeletal muscle metabolism in critically ill patients: Free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med 24:575-583
80. Müller-Werdan U, Pfeifer A, Hübner G, Seliger C, Reithmann C, Rupp H, et al (1997) Partial inhibition of protein synthesis by Pseudomonas exotoxin A deranges catecholamine sensitivitiy of cultured rat heart myocytes. Mol Cell Cardiol (im Druck)
81. Shangraw RE, Jahoor F, Wolfe RR, Lang CH (1996) Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Crit Care Med 24:566-574
82. Boekstegers P, Zell R, Geek P, v. Jagow G, Werdan K (1995) Ist die Aktivitätsabnahme der Pyruvat-Dehydrogenase (PDH) nach Zytokin-Exposition mit TNF-α oder IL la die Folge der primaren Hemmung der mitochondrialen Atmungskette? Z Kardiol 84 [Suppl] 1:559A
83. Gordonj BR, Parker TS, Levine DM, Saal SD, Wang JCL, Sloan B-J, et al (1996) Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia. Crit Care Med 24:584-589
84. Hotchkiss RS, Karl IE (1992) Reevaluation of the role of cellular hypoxia and bioenersetic failure in sepsis. JAMA 267:1503-1510
85. McDonaugh KH, Lang CH, Spitzer JJ (1985) The effect of hyperdynamic sepsis in myocardial performance. Circulatory Shock 15:247-259
86. Pasque MK, Murphy CE, Van Trigt P Pellom GL, Currie WD, Wechsler AS (1983) Myocardial adenosine triphosphate levels during early sepsis. Arch Surg 118:1437-1440
87. Schlag G, Redl H, Davies J, van Vuuren CJJ, Smuts P (1993) Live Escherichia coli sepsis models in baboons. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York Tokyo, pp 1076-1107
88. Gross WL, Bak MI, Ingwall JS, Arstall MA, Smith TW, Balligand J-L et al (1996) Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci USA 93:5604-5609
89. Rupp H, Müller U, Werdan K (1994) Metabolically deranged cardiomyopathy of the trauma-sepsis-syndrome. In: Nagano M, Takeda N, Dhalla NS (eds) The cardiomyopathic heart. Raven Press, New York, pp 257-267
90. Werdan K, Müller-Werdan U (1996) Elucidating molecular mechanisms of septic cardiomyopathy - the cardiomyocyte model. Mol Cell Biochem 163/164:291-303
91. Rehring TF, Brew EC, Friese RS, Banerjee A, Harken AH (1996) Clinically accessible cell signaling: second messengers in sepsis and trauma. J Surg Res 60:270-277
92. Kumar A, Parrillo JE (1995) Nitric oxide and the heart in sepsis. In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS (Update in intensive care and emergency medicine 24). Springer, Berlin Heidelberg New York Tokyo, pp 73-99
93. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA et al (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287
94. Newman WH, Zhang L-M, Leeper-Woodford SK, Castresana MR (1996) Human blood vessels release tumor necrosis factor-α from a smooth muscle cell source. Crit Care Med 24:294-297
95. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA et al (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486
96. Thijs LG, Hack CE (1995) Time course of cytokine levels in sepsis (1995) Intensive Care Med 21:S258-S263
97. Fraunberger P, Walli AK, Seidel D (1996) Stellenwert von Zytokinen in der Sepsis-Diagnostik. Infusionsther Transfusionsmed 23 [Suppl] 4:109-116
98. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL (1996) Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487-1493
99. Boekstegers P, Kainz I, Giehrl W, Peter W, Werdan K (1996) Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor α attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations Mol Cell Biochem 156:135-143
100. Balligand J-L, Ungureanu-Longrois D, Simmons WW, et al (1994) Cytokine-inducible nitric oxide symthase (iNOS) expression in cardiac myocytes, characterization and regulation of iNOS expression and deletion of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 44:27580-27588
101. Thoenes M, Förstermann U, Tracey WR, Bleese NM, Nussler AK, Scholz H et al (1996) Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28:165-169
102. Shah AM (1995) Influence of nitric oxide on cardiac systolic and diastolic function. In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS (Update in intensive care and emergency medicine 24, Vincent J-L, series editor). Springer. Berlin Heidelberg New York Tokyo, pp 100-113
103. Preiser J-C, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, et al (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259-264
104. Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Siewert JR (1994) Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor α and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 2:398-401
105. Wong HR, Carcillo JA, Burckart G, Shah N, Janosky JE (1996) Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 24: 835-842
106. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, et al (1995) L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258
107. Wilkinson J, Sriskandan S, Cohen J (1995) Nitric oxide as a mediator in Gram-positive sepsis. In: Fink MP. Payen D (eds) Role of nitric oxide in sepsis and ARDS (Update in intensive care and emergency medicine 24, Vincent J-L, series editor). Springer, Berlin Heidelberg New York Tokyo, pp 62-69
108. Wyeth RP, Temma K, Seifen E, Kennedy RH (1996) Negative inotropic actions of nitric oxide require high doses in rat cardiac muscle. Pflugers Arch - Eur J Physiol 432:678-684
109. 2) synthesis in rat cardiomyocytes. Naunyn-Schmiedeberg's Arch Pharmacol 349:175-182
110. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-α in adult mammalian heart. J Clin Invest 92:2303-2312
111. 2+current in cardiomyocytes. Am J Physiol 260: H869-H876
112. Hallström S, Bernhart E, Müller U, Fürst W, Vogl C, Koidl B et al (1994) A cardiodepressant factor (CDF) isolated from hemofiltrates of patients in septic and/or cardiogenic shock blocks calcium inward current in cardiomyocytes. Shock [Suppl] 2:abstracts 15
113. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE (1996) Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958
114. Herbertson M, Werner HA, Studer W, Russell JA, Walley KR (1996) Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen. Crit Care Med. 24:815-819
115. Heeg K (1996) Superantigene - Bedeutung als Sepsisinduktoren. Infusionsther Transfusionsmed 23 [Suppl] 4:15-21
116. Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S (1996) Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci USA 93:7882-7887
117. Neuhof H, Soeparwata R, Neuhof C, Scheld HH (1996) Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass Intensivther Transfusionsmed 23 [Suppl] 4:22-28
118. Jones RO, Carlson DE, Gann DS (1994) A circulating shock protein that depolarizes cells in vitro depresses myocardial contractility and rate in isolated rat hearts. J Trauma 37:752-758
119. Werdan K, Müller-Werdan U (1996) Schock, Kollaps und akute Kreislaufinsuffizienz. In: Erdmann E, Riecker G (Hrsg) Klinische Kardiologie. Springer, Berlin Heidelberg New York Tokyo, S 647-736
120. Ognibene FP (1996) Hemodynamic support during sepsis. Clinics Chest Med 17:279-287
121. Witthaut R, Werdan K (1996) Ergebnisforschung am Beispiel der Sepsis. Internist 37:1249-1259
122. Connors AF, Speroff T, Dawson NV, Thomas C, Harrell FE, Wagner D, et al, for the SUPPORT Investigators (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889-897
123. Dalen JE, Bone RC (1996) Is it time to pull the pulmonary artery catheter? JAMA 276:916-918
124. Coalition for Critical Care Excellence (1995) Standards of evidence for the safety and effectiveness of critical care monitoring devices and related interventions. Crit Care Med 23:1756-1763
125. Fiddian-Green RG, Haglund U, Gutierrez G, Shoemaker WC (1993) Goals for the resuscitation of shock. Crit Care Med 21:S25
126. Thijs LG (1995) Fluid therapy in septic shock. In: Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of sepsis (Update in intensive care and emergency medicine 19. Vincent J-L, series editor). Springer, Berlin Heidelberg New York Tokyo, pp 167-190
127. Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent J-L (1996) Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 22:404-408
128. Fink MP (1996) Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med 22:1144-1346
129. Lemaire F, Apolone G, Blanch L, Fagon JY, Foex P, Hedenstierna G et al (1996) Tissue hypoxia - How to detect, how to correct, how to prevent? Care Med 22: 1250-1257
130. Sakka SG, Reinhart K (1996) Volumentherapie im septischen Schock. Intensiv- und Notfallbehandlung 21:73-79
131. Packman MI, Rackow EC (1983) Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 11:165-169
132. Fang K, Krahmer RL, Rypins EB, Law WR (1996) Starling resistor effects on pulmonary artery occlusion pressure in endotoxin shock provide inaccuracies in left ventricular compliance assessments. Crit Care Med 24:1618-1625
133. Rudis MI, Basha MA, Zarowitz BJ (1996) Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24:525-537
134. Day NPJ, Phu NH, Bethell DP, Mai NTH, Chau TTH, Hien TT, et al (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348:219-223
135. Reinhart K, Bloos F, Spies C (1995) Vasoactive drug therapy in sepsis. In. Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of sepsis (Update in intensive care and emergency medicine 19: Vincent J-L. series editor). Springer, Berlin Heidelberg New York Tokyo, pp 207-224
136. Maynard ND, Bihari DJ, Dalton R, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically ill. Chest 108:1648-1654
137. Prough DS (1996) Still lethal after all these years (1996) Crit Care Med 24:189-190
138. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJM, the French Study Group on Acute Renal Failure (1996) Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med 24:192-198
139. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM, for the Auriculin Anaritide Acute Renal Failure Study Group (1996) Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 101:49-53
140. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB et al (1993) Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21:56-61
141. Thompson BT, Cockrill BA (1994) Renal-dose dopamine: a Siren song? Lancet 344:7-8
142. Lherm T, Troché G, Rossignol M, Bordes P, Zazzo JF (1996) Renal effects of low-dose dopamine in patients wih sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 22:213-219
143. Bonde J, Lauritsen HK, Steinberg M, Kamp-Jensen M, Olsen NV (1996) Low-dose dopamine in surgical and intensive care unit patients. Acta Anaestesiol Scand 40: 326-330
144. Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K (1993) Desensitisation of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ Shock 41:48-59
145. Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996) Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 24:835-844
146. Tsuneyoshi I, Kanmura Y, Yoshimura N (1996) Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med 24:1083-1086
147. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD (1996) Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β. Br J Pharmacol 118:1359-1366
148. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717-1722
149. 2 collaborative group (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333:1025-1032
150. Redl G, Germann P, Plattner H, Hammerle A (1993) Right ventricular function in early septic shock states. Intensive Care Med 19:3-7
151. Dhainaut J-F, Lanore J-J, Brunet F (1992) Right ventricular dysfunction in sepsis. In: Peter K, Lawin P, Bein T, Pollwein B, Schelling G (Hrsg) Intensivmedizin 1992 (Intensivmedizin Notfallmedizin Anästhesiologie Band 81, Reihen-Hrsg: Lawin P, v. Loewenich V, Schuster H-P, Stoeckel H, Zumtobel V). G Thieme, Stuttgart New York, S 89-93
152. Holzmann A, Hurford WE, Zapol WM (1996) Inhaliertes Stickoxid: State-of-the-Art. Intensivmed 33:89-96
153. Puybasset L, Rouby JJ (1996) Inhalation of nitric oxide in acute respiratory distress syndrome. Intensivmed 33: 140-152
154. Cheifetz IM, Craig DM, Kern FH, Black DR, Hillman ND, Greeley WJ, et al (1996) Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. Crit Care Med 24:1554-1561
155. Werdan K (1995) Towards a more causal treatment of septic cardiomyopathy. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine 1995. Springer, Berlin Heidelberg New York Tokyo, pp 518-538
156. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, van Zanten ARH, Huipen HJC, Groeneveld ABJ (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal piss. J Crit Care 8:161-169
157. Thiemermann C (1996) Nitric oxide inhibition in circulatory shock: risks and benefits. In: Dellinger RP, Burcharid H, Dobb GJ, Bion J (eds) Current topics in intensive care. WB Saunders, London Philadelphia Toronto Sydney Tokyo, pp 231-246
158. Bhagat K, Vallance P (1996) Inducible nitric oxide synthase in the cardiovascular system. Heart 75:218-220
159. Wet C-M, Jiang S-W, Lust JA, Daly RC, McGregor CGA (1996) Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin Proc 71:346-350
160. Myers PR, Gupta M, Rogers S, Mattox ML, Adams HR, Parker JL (1996) Chronic endotoxemia and endothelium-dependent vasoduation in coronary arteries. Shock 6: 267-273
161. Mery P-F, Hove-Madsen L, Chesnais J-M, Hartzell HC, Fischmeister R (1996) Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart. Am J Physiol 270:H1178-H1188
162. Kaszaki J, Wolfard A, Bari F, Boros M, Parratt JR, Nagy S (1996) Effect of nitric oxide synthase inhibition on myocardial contractiltiy in anesthetized normal and endotoxemic dogs. Shock 6:279-285
163. Kilburn RG, Griffith OW (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831
164. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW (1996) Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by polysaccharide treatment in vivo in the rat. Crit Care Med 24:1219-1225
165. Palmer RMJ (1993) The discovery of nitric oxide in the vessel wall - A
166. Fink M, Payen D (1996) The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995. Intensive Care Med 22:158-165
167. Cobb JP, Danner RL (1996) Nitric oxide and septic shock. JAMA 275:1192-1196 (Letters to the Editor: 1996; 276:781-782)
168. Lorente JA, Landin L, de Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287-1295 (Letters to the Editor: 1995;25:412-415)
169. Lorente JA, Landin L, Canas P, Delgado MA, Albaya A, Renes E, et al (1996) Effects of nitric oxide synthase inhibition on the cardiovascular response to low output shock. Crit Care Med 24:482-487
170. Curzen NP, Jourdan KB, Mitchell JA (1996) Endothelial modification of pulmonary vascular tone. Intensive Care Med 22:596-607
171. G-nitro-L-arginine infusion in porcine endotoxin shock. Crit Care Med 23:909-918
172. Ognibene FP, Cunnion RE (1993) Mechanisms of myocardial depression in sepsis. Crit Care Med 21:6-8
173. Böhm M, Kirchmayr R, Gierschik P, et al (1995) Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multioraan failure. Am J Med 98:183-186
174. Reithmann C, Gierschik P, Jakobs KH, Werdan K (1991) Regulation of adenylyl cyclase by noradrenaline and tumour necrosis factor α in rat cardiomyocytes. Eur Heart J 12 [Suppl] F:139-142
175. Vincent J-L, Bakker J, Marecaux G, Schandene L, Kahn RJ, Dupont E (1992) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101:810-815
176. 2 fragment of an anti-tumor necrosis factor α monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels. Shock 1:237-245
177. Pilz G, Appel R, Gurniak T, Bujdoso O, Werdan K (1992) APACHE II und Elebute Score-Berechnung und Sepsisbe-urteilung auf der Intensivstation anhand eines BASIC Computerprogramms. Intensivmedizin 29:81-89
178. Werdan K, Reithmann C (1992) Differentialtherapie mit Katecholaminen. In: Schuttler J, Schwilden H, Lauven PM (Hrsg) Klinische Pharmakologie und rationale Arzneimit-teltherapie-Symposium, Bonn 1990. G Thieme. Stuttgart New York, S 133-143
179. Reithmann C, Werdan K (1995) Klinische Ergebnisse der einzelnen therapeutischen Prinzipien: Katecholamine. In: Griebenow R, Gülker H, Dominiak P, Piper HM (Hrsg) Autonomes Nervensystem und Herzinsuffizienz. G Thieme, Stuttgart New York, S 214-229
180. Bone R (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125-1128
181. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
182. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477
183. Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:26-34
184. Coraim F, Trubel W, Ebermann R, Werner T (1991) Isolation of low-molecular-weight peptides in hemofiltrated patients with cardiogenic shock: a new aspect of myocardial depressant substances. Contrib Nephrol 93:237-240
185. Sibbald WJ, Vincent J-L (1995) Roundtable conference on clinical trials for the treatment of sepsis. Chest 107: 522-527
186. Roussos C, Zakynthinos S (1996) Fatigue of the respiratory muscles. Intensive Care Med 22:134-155
187. Weber A, Mathru M, Rooney MW (1996) Effect of jet ventilation on heart failure: Decreased afterload but negative response in left ventricular end-systolic pressure-volume function. Crit Care Med 24:647-657
188. Borelli M, Fumagalli R, Bernasconi F, Cereda M, Gattinoni L, Pesenti A (1996) Relief of hypoxemia contributes to a reduction in cardiac index related to the use of positive end-expiratory pressure. Intensive Care Med 22:382-386
189. Peters J (1996) Pathophysiologie der Beatmung: Effekte auf Kreislauf und Orsanfunktion. Intensivmed 33: 101-112
190. Thorens J-B, Jolliet P, Ritz M, Chevrolet J-C (1996) Effects of rapid permissive hypercapnia on hemodynamics, gas exchange, and oxygen transport and consumption during mechanical ventilation for the acute respiratory distress syndrome. Intensive Care Med 22:182-191
191. Peake SL, Moran JL, Leppard PI (1996) N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock Crit Care Med 24:1302-1310
192. Weingartner R, Oliveira E, Santana UL, Oliveira ES, Oliveira R, Azambuja LA, Friedman G (1996) Acute effects of methylene blue in septic shock. Shock [Suppl] 6: Abstracts 24
193. Zeni F, Pain P, Vindimian M, Gay J-P, Gery P, Bertrand M, et al (1996) Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study. Crit Care Med 24:207-214
194. Quezado ZMN, Natanson C, Alling DW, Banks SM, Koev CA, Elin RJ et al (1993) A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269:2221-2227
195. Briegel J, Forst H, Haller M, Lenhart F-P, Kellermann W, Bein T (1992) Neue Möglichkeilen der therapeutischen Intervention beim septischen Shock. In: Peter K, Lawin P, Bein T, Pollwein B, Schelling (Hrsg) Intensivmedizin 1992 (Intensivmedizin Notfallmedizin Anästhesiologie, Reihen-Hrsg: Lawin P, v Loewenich V, Schuster H-P, Stoeckel H, Zumtobel V). Thieme, Stuttgart New York, S 104-118
196. Cobb JP, Cunnion RE, Danner RL (1993) Nitric oxide as a target for therapy in septic shock. Crit Care Med 21: 1261-1263 (Letters to the Editor: 1995;23:412-415)
197. Hata JS, Dellinger RP (1995) Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 23:1621-1624 (Letters to the Edítor: 1996;24:1422-1423)
198. Puybasset L, Bea M-L, Ghaleh B, Giudicelli J-F, Berdeaux A (1996) Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs - evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res 79:343-357
199. Daemen-Gubbels CRGH, Groeneveld PHP, Groeneveld ABJ et al (1995) Methylene blue increases myocardial function in septic shock. Crit Care Med 23:1363-1370 (Letters to the Editor: 1996;24:1093-1094)
200. Palchetti JC (1996) Hemodynamic effects of methylene blue in septic shock: preliminary report. Shock [Suppl] 6:Abstracts 24